Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 2000, p. 511-521, Vol. 44, No. 3
INSERM U479, Laboratoire d'Hématologie
et Immunologie, CHU X. Bichat, 75018 Paris,1 and
Antiinfective Research Department, Hoechst-Marion-Roussel,
93235 Romainville Cedex,2 France
Received 13 July 1999/Returned for modification 28 October
1999/Accepted 29 November 1999
Cytokines, the hallmarks of infectious and inflammatory diseases,
modify phagocyte activities and thus may interfere with the
immunomodulating properties of antibacterial agents. We have investigated whether various proinflammatory cytokines (interleukin 1 [IL-1], IL-6, IL-8, gamma interferon, tumor necrosis factor alpha
[TNF-
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Effect of Proinflammatory Cytokines on the
Interplay between Roxithromycin, HMR 3647, or HMR 3004 and Human
Polymorphonuclear Neutrophils
], and granulocyte-macrophage colony-stimulating factor [GM-CSF]) modify two macrolide properties, i.e., inhibition of oxidant production by polymorphonuclear neutrophils (PMN) and cellular
uptake. Roxithromycin and two ketolides, HMR 3647 and HMR 3004, were
chosen as the test agents. TNF-
and GM-CSF (but not the other
cytokines) decreased the inhibitory effect of HMR 3647 only on oxidant
production by PMN. Fifty percent inhibitory concentrations were,
however, in the same range in control and cytokine-treated cells (about
60 to 70 µg/ml), suggesting that HMR 3647 acts downstream of the
priming effect of cytokines. In contrast, the impairment of oxidant
production by roxithromycin and HMR 3004 was unchanged (or increased)
in cytokine-treated cells. This result suggests that HMR 3004 (the
strongest inhibitory drug, likely owing to its quinoline side chain)
and roxithromycin act on a cellular target upstream of cytokine action.
In addition, TNF-
and GM-CSF significantly (albeit moderately)
impaired (by about 20%) the uptake of the three molecules by PMN. The
inhibitory effect of these two cytokines seems to be related to
activation of the p38 mitogen-activated protein kinase. Our data also
illuminate the mechanism underlying macrolide uptake: protein kinase A-
and tyrosine kinase-dependent phosphorylation seems to be necessary for
optimal uptake, while protein kinase C activation impairs it. The
relevance of our data to the clinical setting requires further
investigations, owing to the complexity of the cytokine cascade during
infection and inflammation.
*
Corresponding author. Mailing address: INSERM U479, CHU
X. Bichat, 46 Rue H. Huchard, 75018 Paris, France. Phone: 33 1 44 85 62 06. Fax: 33 1 44 85 62 07. E-mail: labro{at}bichat.inserm.fr.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |